Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”

19 hours ago 5

Rameen Kasana

Sat, June 13, 2026 astatine 10:31 AM CDT 2 min read

MannKind Corporation (NASDAQ:MNKD) is among the hidden penny stocks to put in. On June 1, Wells Fargo lifted the terms people connected MannKind Corporation (NASDAQ:MNKD) to $11 from $10 and reiterated an Overweight rating. The steadfast associated this people hike with Afrezza's support successful pediatric patients, saying that the company's commercialized imaginable is simply a "show-me story."

The FDA support of Afrezza Inhalation Powder for children and adolescents aged 6 and older with benignant 1 and benignant 2 diabetes is strengthened by results from the pivotal INHALE-1 objective trial. This announcement connected May 29 extends Afrezza's availability beyond adults, present catering to pediatric patients and caregivers arsenic well. No wonderment MannKind Corporation (NASDAQ:MNKD) is among the hidden penny stocks to put in.

Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration

Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration

Copyright: dolgachov / 123RF Stock Photo

During its Q1 2026 net call, MannKind Corporation (NASDAQ:MNKD) outlined the imaginable to person up to $35 cardinal successful improvement milestones, successful summation to a 10% royalty connected nett sales. What's adjacent much awesome is the company's presumption arsenic the sole shaper of Tyvaso DPI nether a proviso agreement. Highlighting the company's strengths, CEO Michael Castagna said,

"The institution is fundamentally antithetic than it was adjacent a fewer years ago. We are excited astir the near-term milestones that volition further beforehand the company's evolution."

MannKind Corporation (NASDAQ:MNKD) is simply a Connecticut-based biopharmaceutical institution that specializes successful chronic illness care. Incorporated successful 1991, the institution provides solutions for superior conditions, specified arsenic diabetes, pulmonary hypertension, and fluid overload.

While we admit the imaginable of MNKD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article